JP2007514769A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007514769A5 JP2007514769A5 JP2006545566A JP2006545566A JP2007514769A5 JP 2007514769 A5 JP2007514769 A5 JP 2007514769A5 JP 2006545566 A JP2006545566 A JP 2006545566A JP 2006545566 A JP2006545566 A JP 2006545566A JP 2007514769 A5 JP2007514769 A5 JP 2007514769A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic agent
- medical condition
- heart disease
- angina
- diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims 4
- 229940124597 therapeutic agent Drugs 0.000 claims 4
- 208000019622 heart disease Diseases 0.000 claims 3
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 2
- 206010019280 Heart failures Diseases 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 206010002383 Angina Pectoris Diseases 0.000 claims 1
- 206010002388 Angina unstable Diseases 0.000 claims 1
- 206010003130 Arrhythmia supraventricular Diseases 0.000 claims 1
- 206010022562 Intermittent claudication Diseases 0.000 claims 1
- 208000007718 Stable Angina Diseases 0.000 claims 1
- 208000007814 Unstable Angina Diseases 0.000 claims 1
- 206010047281 Ventricular arrhythmia Diseases 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 201000004332 intermediate coronary syndrome Diseases 0.000 claims 1
- 208000021156 intermittent vascular claudication Diseases 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 230000035939 shock Effects 0.000 claims 1
- 210000002027 skeletal muscle Anatomy 0.000 claims 1
- 230000008733 trauma Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53125303P | 2003-12-18 | 2003-12-18 | |
| PCT/US2004/042859 WO2005061470A1 (en) | 2003-12-18 | 2004-12-17 | 1-akan-2-ol substituted piperazine and piperidine compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007514769A JP2007514769A (ja) | 2007-06-07 |
| JP2007514769A5 true JP2007514769A5 (enExample) | 2008-01-24 |
Family
ID=34710215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006545566A Pending JP2007514769A (ja) | 2003-12-18 | 2004-12-17 | １−アルカン−２−オール置換ピペラジンおよびピペリジン化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US7115610B2 (enExample) |
| EP (1) | EP1723129A1 (enExample) |
| JP (1) | JP2007514769A (enExample) |
| KR (1) | KR20060124646A (enExample) |
| AU (1) | AU2004303882A1 (enExample) |
| CA (1) | CA2550257A1 (enExample) |
| WO (1) | WO2005061470A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005061470A1 (en) * | 2003-12-18 | 2005-07-07 | Cv Therapeutics, Inc. | 1-akan-2-ol substituted piperazine and piperidine compounds |
| EP1829866A1 (en) * | 2006-03-02 | 2007-09-05 | Laboratorios Del Dr. Esteve, S.A. | Sigma receptor inhibitors |
| JP5566288B2 (ja) | 2008-05-30 | 2014-08-06 | 武田薬品工業株式会社 | 複素環化合物 |
| CN105175401A (zh) * | 2015-10-16 | 2015-12-23 | 北京康立生医药技术开发有限公司 | 一种依匹哌唑的制备方法 |
| EP4334293A1 (en) * | 2021-05-07 | 2024-03-13 | Merck Sharp & Dohme LLC | Cycloalkyl 3-oxopiperazine carboxamides and cycloheteroalkyl 3-oxopiperazine carboxamides as nav1.8 inhibitors |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2034305B (en) | 1978-10-24 | 1982-12-22 | Wyeth John & Brother Ltd | Preparation of piperidine derivatives |
| DE3118881A1 (de) | 1980-09-29 | 1982-06-24 | Oltmanns Ziegel Und Kunststoffe Gmbh, 2905 Edewecht | "ziegel" |
| US4766125A (en) | 1981-06-23 | 1988-08-23 | Janssen Pharmaceutica N.V. | N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia |
| US4558129A (en) | 1983-05-18 | 1985-12-10 | Syntex (U.S.A.) Inc. | Benzodioxanyl-hydroxyethylene-piperazinyl acetanilides which effect calcium entry and β-blockade |
| US4567264A (en) | 1983-05-18 | 1986-01-28 | Syntex (U.S.A.) Inc. | Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry |
| NZ247044A (en) | 1989-06-23 | 1997-04-24 | Syntex Usa Inc Substituted For | Use of ranolazine and related piperazine derivatives to treat tissue affected by muscle and neuronal damage, including transplant tissue |
| HU209723B (en) * | 1990-10-31 | 1994-10-28 | Richter Gedeon Vegyeszet | Process for producing of piperazine derivatives |
| US5455045A (en) | 1993-05-13 | 1995-10-03 | Syntex (U.S.A.) Inc. | High dose formulations |
| CN1227004C (zh) * | 2000-02-18 | 2005-11-16 | Cv治疗公司 | 治疗充血性心力衰竭的部分脂肪酸氧化抑制剂 |
| MXPA02008213A (es) * | 2000-02-22 | 2004-04-05 | Cv Therapeutics Inc | Compuestos piperazina sustituidos. |
| US6552023B2 (en) | 2000-02-22 | 2003-04-22 | Cv Therapeutics, Inc. | Aralkyl substituted piperazine compounds |
| US6677336B2 (en) | 2000-02-22 | 2004-01-13 | Cv Therapeutics, Inc. | Substituted piperazine compounds |
| US6451798B2 (en) | 2000-02-22 | 2002-09-17 | Cv Therapeutics, Inc. | Substituted alkyl piperazine derivatives |
| AU2001238590A1 (en) | 2000-02-22 | 2001-09-03 | Cv Therapeutics, Inc. | Substituted piperazine compounds |
| CN1240688C (zh) * | 2000-04-07 | 2006-02-08 | 阿斯特拉曾尼卡有限公司 | 喹唑啉化合物 |
| US6573264B1 (en) | 2000-10-23 | 2003-06-03 | Cv Therapeutics, Inc. | Heteroaryl alkyl piperazine derivatives |
| US7001909B2 (en) | 2001-07-19 | 2006-02-21 | Cv Therapeutics, Inc. | Substituted heterocyclic compounds |
| DE60203623T2 (de) | 2001-07-19 | 2006-01-19 | CV Therapeutics, Inc., Palo Alto | Substituierte piperazinderivate und ihre verwendung als fettsaüre-oxidationsinhibitoren |
| US6827946B2 (en) * | 2001-12-05 | 2004-12-07 | Collegium Pharmaceutical, Inc. | Compositions containing both sedative and non-sedative antihistamines |
| AU2003206954A1 (en) * | 2002-03-05 | 2003-09-16 | Ciba Specialty Chemicals Holding Inc. | Colour photographic recording material |
| US20030220344A1 (en) * | 2002-04-04 | 2003-11-27 | Luiz Belardinelli | Method of treating arrhythmias |
| WO2005061470A1 (en) * | 2003-12-18 | 2005-07-07 | Cv Therapeutics, Inc. | 1-akan-2-ol substituted piperazine and piperidine compounds |
-
2004
- 2004-12-17 WO PCT/US2004/042859 patent/WO2005061470A1/en not_active Ceased
- 2004-12-17 AU AU2004303882A patent/AU2004303882A1/en not_active Abandoned
- 2004-12-17 JP JP2006545566A patent/JP2007514769A/ja active Pending
- 2004-12-17 CA CA002550257A patent/CA2550257A1/en not_active Abandoned
- 2004-12-17 US US11/015,915 patent/US7115610B2/en not_active Expired - Lifetime
- 2004-12-17 EP EP04814988A patent/EP1723129A1/en not_active Withdrawn
- 2004-12-17 KR KR1020067011920A patent/KR20060124646A/ko not_active Ceased
-
2006
- 2006-06-13 US US11/452,479 patent/US7262198B2/en not_active Expired - Lifetime
-
2007
- 2007-08-27 US US11/845,720 patent/US7452889B2/en not_active Expired - Lifetime
-
2008
- 2008-10-27 US US12/259,085 patent/US20090054457A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006526031A5 (enExample) | ||
| JP2006519232A5 (enExample) | ||
| JP2005508905A5 (enExample) | ||
| JP2010501534A5 (enExample) | ||
| JP2007522220A5 (enExample) | ||
| DK1370530T3 (da) | Acyleret 1,2,3,4-tetrahydronaphtylaminer og anvendelse deraf som farmaceutisk produkt | |
| WO2005082863A3 (en) | 1,4 diaryl-dihydropyrimidin-2 ones and their use as a human neutrophil elastase inhibitors | |
| CA2698332A1 (en) | Pyrazole derivatives as soluble guanylate cyclase activators | |
| JP2003531118A5 (enExample) | ||
| NO20032766L (no) | Terapeutisk forening av amlodipin og benazepril | |
| NO20040234L (no) | Substituerte piperazinforbindelser og anvendelse av disse som inhibitorer for oksydasjon av fettsyrer | |
| JP2004002446A5 (enExample) | ||
| JP2007514769A5 (enExample) | ||
| NO20070148L (no) | Nye oksabispidinforbindelser og deres anvendelse ved behandling av forstyrrelser i hjerterytmen | |
| JP2007521013A5 (enExample) | ||
| JP2006525972A5 (enExample) | ||
| JP2006298895A5 (enExample) | ||
| CA2400176A1 (en) | Substituted piperazine compounds | |
| JP2009055850A5 (enExample) | ||
| NO20070147L (no) | Nye oksabispidinforbindelser og deres anvendelse ved behandling av forstyrrelser i hjerterytmen | |
| JP2004517961A5 (enExample) | ||
| JP2008505852A5 (enExample) | ||
| ATE443058T1 (de) | Substituierte heterozyklische verbindungen | |
| JP2007048462A5 (enExample) | ||
| NO20076052L (no) | Nye oksabispidinforbindelser for behandling av forstyrrelser i hjerterytmen |